PLASMA-FIBRINOGEN AND PHYSIOLOGICAL AGING

被引：21

作者：

LAHARRAGUE, PF

CAMBUS, JP

FILLOLA, G

CORBERAND, JX

机构：

[1] Service d’Hématologie, CHU Toulouse-Rangueil, Toulouse

来源：

AGING-CLINICAL AND EXPERIMENTAL RESEARCH | 1993年 / 5卷 / 06期

关键词：

AGING; ARTERIOSCLEROSIS; COAGULATION; FIBRINOGEN;

D O I：

10.1007/BF03324200

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

Results of prospective studies indicate that increased fibrinogen concentration is significantly associated with the risk of arteriosclerotic vessel disease. As the fibrinogen concentration is considered to rise with aging, determination of its physiological values with various methods in strictly healthy adult and aged individuals is a prerequisite to evaluating the relative contribution of fibrinogen to cardiovascular diseases. Fibrinogen concentration was determined in 209 healthy subjects, aged 19 to 96 years. Persons over the age of 60 were recruited according to the stringent criteria of the Senieur protocol established for human immunogerontological studies. Fibrinogen concentrations, obtained by heating precipitation and by thrombin clotting time with both electromagnetic water-bath and semiautomatic coagulometer, ranged from 1.55 to 3.70 g/L. A rise in plasma concentration was observed with aging. Independently of age, females exhibited higher concentrations than males. Significantly higher values were observed in subjects over 60 years of age, in both sexes, in comparison with the younger groups.

引用

页码：445 / 449

页数：5

共 20 条

[1]

Meade T.W., North W.R.S., Chakrabarti R.R., Stirling Y., Haines A.P., Thompson S.G., Haemostatic function and cardiovascular death: early results of a prospective study, Lancet, 1, pp. 1050-1054, (1980)

[2]

Meade T.W., Mellows S., Brozovic M., Miller S.G., Chakrabarti R.R., North W.R.S., Haines A.P., Stirling Y., Imeson J.D., Thompson S.G., Haemostatic function and ischaemic heart disease. Principal results of the Northwick Park heart study, Lancet, 2, pp. 533-537, (1986)

[3]

Baker I.A., Eastham R., Elwood P.C., Etherington M., O'Brien J.R., Sweetnam P.M., Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years, The Speedwell study. Br. Heart J., 14, pp. 490-494, (1982)

[4]

O'Connor N.T.J., Cederholm-Willia S., Copper S., Cotter L., Hypercoagulability and coronary artery disease, Br. Heart J., 52, pp. 614-616, (1984)

[5]

Wilhelen L., Svardsudd K., Korsan-Bengsten K., Larsson B., Welin L., Tibblin G., Fibrinogen as a risk factor for stroke and myocardial infarction, N. Engl. J. Med., 311, pp. 501-505, (1984)

[6]

Stone M.C., Thorpe J.M., Plasma fibrinogen — a major coronary risk factor, J. R. Coll. Gen. Pract., 35, pp. 565-569, (1985)

[7]

Kannel W.B., D'Agostino R.B., Belanger A.J., Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham study, Am. Heart J., 113, pp. 1006-1010, (1987)

[8]

Exner T., Burridge J., Power P., Rickard K.A., An evaluation of currently available methods for plasma fibrinogen, Am. J. Clin. Pathol., 71, pp. 521-527, (1979)

[9]

Jespersen J., Sidelman J., A study of the conditions and accuracy of the thrombin time assay of plasma fibrinogen, Acta Haematol., 67, pp. 2-7, (1982)

[10]

Palareti G., Maccaferri M., Manotti C., Tripodi A., Chantarangkul V., Rodeghiero F., Ruggeri M., Mannucci P.M., Fibrinogen assays: a collaborative study of six different methods, Clin. Chem., 37, pp. 714-719, (1991)

← 1 2 →